Literature DB >> 20470048

Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies.

William M Geisler1.   

Abstract

The majority of Chlamydia trachomatis genital infections in humans are asymptomatic and without clinical evidence of complications at the time of diagnosis. The natural history of chlamydial infection in humans, including the duration of infection and factors influencing resolution of infection, is not yet completely understood. This is in part attributable to the inherent challenges and ethical considerations in studying untreated chlamydia in humans. An improved understanding of the natural history of chlamydia in humans has implications for chlamydia screening and treatment recommendations. In April 2008, the Centers for Disease Control and Prevention convened an advisory group for the Chlamydia Immunology and Control Expert Advisory Meeting, in which studies related to chlamydia natural history, pathogenesis, and immunobiology were reviewed and gaps in our knowledge that would have implications for prevention and control of C. trachomatis infection were identified. This article summarizes the key questions posed and the evidence reviewed on the duration of untreated, uncomplicated genital chlamydial infection in humans and the factors associated with chlamydia resolution.

Entities:  

Mesh:

Year:  2010        PMID: 20470048     DOI: 10.1086/652402

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  78 in total

Review 1.  Antibiotic resistance in Chlamydiae.

Authors:  Kelsi M Sandoz; Daniel D Rockey
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

Review 2.  Human and Pathogen Factors Associated with Chlamydia trachomatis-Related Infertility in Women.

Authors:  S Menon; P Timms; J A Allan; K Alexander; L Rombauts; P Horner; M Keltz; J Hocking; W M Huston
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

3.  Potential protective effect of a G>A SNP in the 3'UTR of HLA-A for Chlamydia trachomatis symptomatology and severity of infection.

Authors:  Marleen E Jansen; Ivan Branković; Joke Spaargaren; Sander Ouburg; Servaas A Morré
Journal:  Pathog Dis       Date:  2015-12-09       Impact factor: 3.166

4.  Characterization of the Horizontal and Vertical Sexual Transmission of Chlamydia Genital Infections in a New Mouse Model.

Authors:  Sukumar Pal; Delia F Tifrea; Luis M de la Maza
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

Review 5.  Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies.

Authors:  Byron E Batteiger; Fujie Xu; Robert E Johnson; Michael L Rekart
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

6.  Microbiological Characteristics of Chlamydia trachomatis and Neisseria gonorrhoeae Infections in South African Women.

Authors:  Jan Henk Dubbink; Dewi J de Waaij; Myrte Bos; Lisette van der Eem; Cécile Bébéar; Nontembeko Mbambazela; Sander Ouburg; Remco P H Peters; Servaas A Morré
Journal:  J Clin Microbiol       Date:  2015-10-28       Impact factor: 5.948

7.  Chlamydia trachomatis infection in African American women who exclusively have sex with women.

Authors:  Christina A Muzny; Richa Kapil; Erika L Austin; LaDraka Brown; Edward W Hook; William M Geisler
Journal:  Int J STD AIDS       Date:  2015-09-18       Impact factor: 1.359

8.  Cell Intrinsic Factors Modulate the Effects of IFNγ on the Development of Chlamydia trachomatis.

Authors:  Shardulendra Sherchand; Joyce A Ibana; Alison J Quayle; Ashok Aiyar
Journal:  J Bacteriol Parasitol       Date:  2016-07-25

9.  High Rates of Repeat Chlamydial Infections Among Young Women-Louisiana, 2000-2015.

Authors:  Susan Cha; Daniel R Newman; Mohammad Rahman; Thomas A Peterman
Journal:  Sex Transm Dis       Date:  2019-01       Impact factor: 2.830

10.  Repeated Chlamydia trachomatis infections are associated with lower bacterial loads.

Authors:  K Gupta; R K Bakshi; B Van Der Pol; G Daniel; L Brown; C G Press; R Gorwitz; J Papp; J Y Lee; W M Geisler
Journal:  Epidemiol Infect       Date:  2018-10-04       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.